[Estrogen-gestagen substitution in geriatric gynecology. Long-term prevention for the third segment of life after menopause].
On average, post-menopausal women still have one-third of their lives ahead of them. It must be considered a task for the physician through the prophylactic and therapeutic application of estrogen (gestagen) replacement to secure for these women as high a quality of life as possible. The positive effects of replacement treatment affect, for example, the cardiovascular system, the urogenital system, osteoporosis and cognitive and mental functions. An absolute indication for estrogen replacement is very pronounced climacteric symptomatology that negatively influences the patient's quality of life, further marked complaints resulting from atrophic changes to the urogenital system, and manifest osteoporosis at the time of the menopause. Over and beyond this, numerous additional indications for such treatment can be listed, with only few contraindications.
Lauritzen
C
C
D000368:Aged; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D003327:Coronary Disease / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D011372:Progestins / Q000008:administration & dosage*; D012307:Risk Factors
D011372:Progestins
Ostrogen-Gestagen-Substitution in der Altersgynäkologie. Langzeitprävention für das Lebensdrittel nach der Menopause.